Predictions
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€4.84
10.07.22
10.07.22
€7.00
10.07.23
10.07.23
19.42%
23.07.22
23.07.22
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
MorphoSys AG
Start price
Target price
Perf. (%)
€18.69
12.06.22
12.06.22
€28.00
12.06.23
12.06.23
53.93%
13.06.23
13.06.23
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€49.15
01.06.22
01.06.22
-
01.06.23
01.06.23
-2.34%
11.06.22
11.06.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€42.25
01.06.22
01.06.22
-
01.06.23
01.06.23
-0.47%
11.06.22
11.06.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Vita 34 AG
Start price
Target price
Perf. (%)
€11.05
18.05.22
18.05.22
-
18.05.23
18.05.23
-0.45%
28.05.22
28.05.22
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Biofrontera AG
Start price
Target price
Perf. (%)
€1.16
18.05.22
18.05.22
-
18.05.23
18.05.23
2.59%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Undervalued
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€41.80
12.05.22
12.05.22
-
12.05.23
12.05.23
-6.22%
13.05.23
13.05.23
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€48.92
25.04.22
25.04.22
€120.00
03.02.25
03.02.25
-8.73%
29.08.24
29.08.24
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Affimed N.V.
Start price
Target price
Perf. (%)
€4.75
11.04.22
11.04.22
-
11.04.23
11.04.23
-41.07%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.16
09.04.22
09.04.22
-
09.04.23
09.04.23
0.00%
18.04.22
18.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
07.03.22
07.03.22
-
07.03.23
07.03.23
0.60%
19.03.22
19.03.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
MorphoSys AG
Start price
Target price
Perf. (%)
€24.31
01.03.22
01.03.22
€30.00
01.04.22
01.04.22
4.07%
02.04.22
02.04.22
Could be worthwhile Investment >10% per year